CHRD
Chord Energy Corporation
CHRD's fundamentals are strong, but it looks expensive: trading at 9.2x earnings, above its usual 6.8x. Analysts expect strong earnings growth, though they disagree widely on how much.
CHRD Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
CHRD's revenue, profitability, cash flow and balance sheet are all currently strong.
CHRD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3.3x | $52.40 | -64% |
| Fair | 6.7x | $108 | -27% |
| Forward | 6.7x | $147 | — |
| Current | 9.2x | $147 | — |
| Expensive | 23x | $365 | +148% |
Historical ranges are pointers, not guarantees.
CHRD's PE is in its expensive range at 9.2x. If earnings grow as analysts expect, today's price would be 6.7x next year's earnings, in its fair range.
CHRD Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CHRD, with profitability improving. However, they disagree widely on these estimates.
CHRD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.09 | +38% |
| Q3 2026 | $16.06 | +499% |
| Q2 2026 | $15.03 | +275% |
| Q1 2026 | -$1.02 | -107% |
| Q4 2025 | $0.74 | -95% |
| Q3 2025 | $2.68 | -86% |
| Q2 2025 | $4.01 | -81% |
| Q1 2025 | $15.03 | -29% |
| Q4 2024 | $16.02 | -32% |
CHRD's earnings per share have fallen from their peak: $16.06 over the past year, against $61.50 in late 2022.
CHRD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +30% |
| Q2 2026 | $2.2B | +84% |
| Q1 2026 | $1.7B | +37% |
| Q4 2025 | $1.2B | -20% |
| Q3 2025 | $1.3B | -9.5% |
| Q2 2025 | $1.2B | -6.4% |
| Q1 2025 | $1.2B | +12% |
| Q4 2024 | $1.5B | +51% |
CHRD's revenue is growing: $1.7B last quarter, up 30% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | +17 points |
| Q2 2026 | 28% | +62 points |
| Q1 2026 | 20% | -7.8 points |
| Q4 2025 | 7.8% | -10 points |
| Q3 2025 | 13% | -5.8 points |
| Q2 2025 | -34% | -57 points |
| Q1 2025 | 28% | +2.7 points |
| Q4 2024 | 18% | -17 points |
CHRD's operating margin was 30% last quarter, up 17 points from the same quarter a year ago.
CHRD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $781.4M | +40% |
| Q2 2026 | $1.1B | +166% |
| Q1 2026 | $507.5M | -23% |
| Q4 2025 | $405M | -29% |
| Q3 2025 | $559M | -16% |
| Q2 2025 | $419.8M | -8.9% |
| Q1 2025 | $656.9M | +62% |
| Q4 2024 | $566.5M | +4.3% |
CHRD generated $2.8B in free cash flow over the past year, up 28% from the year before.
CHRD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.3% | -1.9M shares |
| 1 year | -4.2% | -2.4M shares |
| 3 years | +25% | +11.1M shares |
| 5 years | +163% | +33.9M shares |
CHRD has 55M diluted shares, down 4.2% from a year ago, with $426M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $201M |
| Q2 2026 | $149.9M |
| Q1 2026 | $67.7M |
| Q4 2025 | $7M |
| Q3 2025 | $83.8M |
| Q2 2025 | $58.9M |
| Q1 2025 | $215.2M |
| Q4 2024 | $204.4M |
CHRD spent $426M buying back its own shares over the past year, down 24% from the year before.
CHRD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.8x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.4x | Very low |
CHRD's net debt is less than a year of its operating earnings (EBITDA).
CHRD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.4 | Neutral |
| Stochastic | 57.3 | Neutral |
CHRD's weekly RSI is 54 (neutral) and its Stochastic is 57 (neutral).
CHRD PE vs Energy Sector
| Metric | CHRD | Sector median | Relative |
|---|---|---|---|
| PE | 9.2x | 13x | 30% below |
| PE % | 77 | 55 | 22 pts above |
CHRD is trading at 9.2x earnings, a 30% discount to the Energy sector's median of 13x.
CHRD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $146.0 | 0.7% above |
| 20 week MA | $140.6 | 4.6% above |
| 50 week MA | $127.1 | 16% above |
| 100 week MA | $114.8 | 28% above |
| 200 week MA | $134.3 | 9.5% above |
CHRD has climbed back above all five of its weekly moving averages, and it's now 9.5% above its 200-week average.
CHRD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.0 | $37.4 | +21% |
| 2021 | $37.4 | $121.5 | +225% |
| 2022 | $121.5 | $139.8 | +15% |
| 2023 | $139.8 | $166.2 | +19% |
| 2024 | $166.2 | $112.1 | -33% |
| 2025 | $112.1 | $90.0 | -20% |
| 2026 YTD | $90.0 | $147.1 | +63% |
CHRD has finished higher in four of the last six years. It's up 63% so far in 2026.